ModelEdge

Jazz Pharmaceuticals
JAZZ
Filing Type10-Q
Filing Date8/5/2025
Updated8/6/25, 5:33 AM

Filing

10-Q
Earnings Release

Exhibits

10-QQ2
EX-10.1ALICENSE AND OPTION AGREEMENT
EX-10.1BAMENDED AND RESTATED LICENSE AND OPTION AGREEMENT
EX-10.2LETTER AGREEMENT
EX-31.1CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-31.2CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-32.1CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
GRAPHICGraphic
GRAPHICGraphic